Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of Deferred ChargesAmortization of Deferred ChargesAsset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in ReceivablesChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Dividends Paid - CommonDividends Paid - CommonFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesGains from Sales and DivestituresGains from Sales and DivestituresLong-Term Debt IssuancesLong-Term Debt RepaymentsNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesSales of Property, Plant and EquipmentSales of Property, Plant and EquipmentShare-based CompensationShare-based CompensationShares RepurchasedShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Acadia Healthcare Company (ACHC) Capital Expenditures (2016 - 2026)

Acadia Healthcare Company (ACHC) has disclosed Capital Expenditures for 17 consecutive years, with $76.6 million as the latest value for Q1 2026.

  • For Q1 2026, Capital Expenditures fell 56.16% year-over-year to $76.6 million; the TTM value through Mar 2026 reached $473.7 million, down 34.44%, while the annual FY2025 figure was $571.8 million, 17.18% down from the prior year.
  • Capital Expenditures hit $76.6 million in Q1 2026 for Acadia Healthcare Company, down from $93.2 million in the prior quarter.
  • Across five years, Capital Expenditures topped out at $203.5 million in Q4 2024 and bottomed at $50.5 million in Q1 2022.
  • Average Capital Expenditures over 5 years is $121.1 million, with a median of $128.1 million recorded in 2023.
  • Year-over-year, Capital Expenditures soared 114.07% in 2024 and then tumbled 56.16% in 2026.
  • Acadia Healthcare Company's Capital Expenditures stood at $87.4 million in 2022, then surged by 58.8% to $138.7 million in 2023, then skyrocketed by 46.69% to $203.5 million in 2024, then plummeted by 54.21% to $93.2 million in 2025, then dropped by 17.84% to $76.6 million in 2026.
  • According to Business Quant data, Capital Expenditures over the past three periods came in at $76.6 million, $93.2 million, and $136.2 million for Q1 2026, Q4 2025, and Q3 2025 respectively.